Close
Digital Health & Ai Innovation summit 2026
Medical Taiwan 2026

Zoll Launches Next-Gen LifeVest Wearable in the U.S.

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

UK Medical Device Testing Jumps 17%,...

Clinical investigations of medical devices in the UK reached...

Medtronic Secures FDA PMA for Infuse...

Medtronic announced that it has secured FDA premarket approval...

Regulatory Trends Shaping Medical Technology

The path from innovation to clinical implementation is governed by an increasingly complex and dynamic set of global standards. As digital health and artificial intelligence become integral to patient care, the frameworks that ensure safety and efficacy are evolving to address the unique challenges of software-based medical solutions and interconnected hardware.

ZOLL, a medical device and related software solutions maker, has gone ahead and introduced its next-gen LifeVest wearable cardioverter defibrillator – WCD in the US.

The latest device, apparently, is the fifth LifeVest WCD, which has secured the Food and Drug Administration – FDA approval.

It is indeed compatible with the recently released next-gen LifeVest garment.

ZOLL went on to note that the device is expected to offer safe and effective therapy for those who are at risk of sudden cardiac death, with high levels of patient compliance, which is supported by data coming from real-world usage and also peer-reviewed publications.

The last three versions have had integrated response buttons within the monitor, enabling the conscious patients to delay the needless treatment.

The two most recent versions are most likely to feature a touchscreen, hence making it way easier for patients to go ahead and engage with system notifications.

The present design, interestingly, goes on to eliminate the need for a separate smartphone-type device, hence helping the patients to interact with the system directly.

ZOLL went on to state that LifeVest is the only WCD that enables this kind of direct interaction without needing an additional device.

As per ZOLL, the number of clinicians as well as patients who choose the LifeVest WCD has grown, with clinical evidence going ahead and supporting the usage of WCDs for newly diagnosed heart failure patients having decreased ejection fraction who are at risk of a sudden cardiac death.

It is well to be noted that the LifeVest garment is customized so as to accommodate daily activities outside the hospital. It has a lightweight and performance-inspired fabric, plush straps, and flat-lock stitching, as well as an array of sizes to fit the chest measurements from 26 inches to 56 inches, said the company.

Mike Blastick, the ZOLL Cardiac Management Solutions president, remarked that ZOLL is always innovating so as to make sure that patients have protection from sudden cardiac death with a solution that goes on to seamlessly integrate within their lives outside of the hospital.

He added that this latest next-gen LifeVest wearable goes on to represent the next step in their mission, which blends advanced technology along with patient-centered design.

Latest stories

Related stories

UK Medical Device Testing Jumps 17%, AI and Neurotech Lead

Clinical investigations of medical devices in the UK reached...

Medtronic Secures FDA PMA for Infuse Bone Graft in TLIF

Medtronic announced that it has secured FDA premarket approval...

Regulatory Trends Shaping Medical Technology

The path from innovation to clinical implementation is governed by an increasingly complex and dynamic set of global standards. As digital health and artificial intelligence become integral to patient care, the frameworks that ensure safety and efficacy are evolving to address the unique challenges of software-based medical solutions and interconnected hardware.

Healthcare Supply Chains Driving Efficiency

The intricate network responsible for delivering life-saving medications and surgical instruments is undergoing a fundamental digital overhaul. By prioritizing transparency and resilience, medical institutions are moving away from reactive procurement toward a proactive logistical model that ensures essential resources are always available at the point of care.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »